CD160 and cancer: Simultaneously, genes promoting anti-cancer efficacy such as Cd160, Cd244a, and Ccr2 were highly expressed while a relay gene of the NF-κB pathway, Card11, was suppressed in NK cells after CBL0137 treatment.